Skip to main content
. 2020 Jul 13;27(10):1137–1142. doi: 10.1097/GME.0000000000001593

TABLE 2.

Summary of treatment-emergent adverse events in participants aged ≥80 years from ACTIVExtend (safety population)a

graphic file with name menop-27-1137-g004.jpg